Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington's...
Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington's disease
About this item
Full title
Author / Creator
Stout, Julie C , Jones, Rebecca , Labuschagne, Izelle , O'Regan, Alison M , Say, Miranda J , Dumas, Eve M , Queller, Sarah , Justo, Damian , Santos, Rachelle Dar , Coleman, Allison , Hart, Ellen P , Dürr, Alexandra , Leavitt, Blair R , Roos, Raymund A , Langbehn, Doug R , Tabrizi, Sarah J and Frost, Chris
Publisher
London: BMJ Publishing Group Ltd
Journal title
Language
English
Formats
Publication information
Publisher
London: BMJ Publishing Group Ltd
Subjects
More information
Scope and Contents
Contents
Background Deterioration of cognitive functioning is a debilitating symptom in many neurodegenerative diseases, such as Huntington's disease (HD). To date, there are no effective treatments for the cognitive problems associated with HD. Cognitive assessment outcomes will have a central role in the efforts to develop treatments to delay onset or slo...
Alternative Titles
Full title
Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington's disease
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3368487
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3368487
Other Identifiers
ISSN
0022-3050
E-ISSN
1468-330X
DOI
10.1136/jnnp-2011-301940
